Sotorasib phase 1 trial shows encouraging anti-cancer activity in lung, colorectal cancers

Sotorasib phase 1 trial shows encouraging anti-cancer activity in lung, colorectal cancers

Sotorasib phase 1 trial shows encouraging anti-cancer activity in lung, colorectal cancers

A phase 1 clinical trial of sotorasib (AMG 510) in patients with heavily pretreated advanced solid tumors shows encouraging anti-cancer activity, especially in lung and colorectal cancers, reports a new study led by City of Hope and other renowned comprehensive cancer centers.